ClinicalTrials.gg
RecruitingNCT07453550Updated May 1, 2026

The Effects of Brief Periods of Exercise on Blood Pressure

An interventional study of wall-squat and wall-squat-tradition in Hypertension (HTN) and Pre Hypertension, sponsored by University of Hartford. Recruiting at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by University of Hartford · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

High blood pressure is a common medical condition that affects the body's arteries. It's also called hypertension. Untreated hypertension increases the risk of heart attack, stroke and other serious health problems. Exercise is a promising tool in hypertension management. Regular participation in exercise improves vascular health, heart and lung function, and multisystem health. However, the direct evidence of the treatment effects of a brief period of exercise on blood pressure in individuals with hypertension is limited. A brief period of exercise refers to an exercise protocol that only lasts for a very short period of time, such as 5-10 minutes.

Read the detailed description

The study will investigate both acute and long-term effects of a brief exercise on blood pressure. For the acute effect, participants will conduct a single bout of resistance exercise (leg press) with or without blood flow restriction technique. The blood pressure changes from pre- to post-exercise will be monitored. The long-term effect of exercise on blood pressure will be examined through a six to eight weeks home-based intervention program. Participants will conduct two forms of exercise, one is a clustered wall-sit exercise and the other is a scattered wall-sit exercise.

02

Conditions studied

  • Hypertension (HTN)
  • Pre Hypertension

Keywords

  • isometric exericse
03

In context

Hypertension

6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.

This study's planned enrollment of 45 is below the median of 100 across 4,575 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

University of Hartford is the lead sponsor of 16 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-55 yrs.
  • 24 hour average BP >110/70 mmHg, but \< 160 systolic blood pressure
  • Able to provide

Exclusion criteria

Exclusion Criteria:

  • Currently taking anti-hypertensive medication smokers and alcohol drinkers Inability to undertake exercise intervention (resistance and isometric exercise)

Current medical history of any of the following:

hyperaldosteronism Diabetes mellitus (Type 1 or type 2) Heart disease Stroke or Peripheral neuropathy Aortic aneurysm and/or peripheral arterial disease If female, pregnancy or currently breast feeding Enrolled in another Clinical Trial of an Interventional Medicinal Product or Medical Device or other interventional study Medical condition that, in the opinion of the investigator, would make the participant unsuitable for the study On long term warfarin Allergies to blood pressure cuff materials or ultrasound gel

Previous medication history of any of the following:

hyperaldosteronism Heart disease Stroke or transient ischemic attack Peripheral neuropathy Aortic aneurysm and/or peripheral arterial disease thromboembolism Infection within limb within 3 months On long term warfarin Allergies to blood pressure cuff materials or ultrasound gel

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
45 participants (estimated)

Study arms

  • No intervention
    Non-Ex control group
  • Active comparator
    Clustered Ex Condition

    Behavioral: wall-squat-tradition

  • Experimental
    Scattered Ex Condition

    Behavioral: wall-squat

Interventions

  • Behavioralwall-squat

    the experimental group will complete the four sets of wall-squats at four different times across the day: morning, noon, afternoon, night.

  • Behavioralwall-squat-tradition

    The other exercise group will do 4 sets of wall squat in a continuous way.

06

What researchers measure

Primary outcomes

  1. 24 h blood pressure

    The average, peak and variations of 24 h SBP and DBP, daytime SBP and DBP, night time SBP and DBP will be measured before and after the intervention.

    Time frame: From the enrollment to the end of the study at six weeks

Secondary outcomes

  1. endothelial function

    endothelial function measured by flow mediated dilation

    Time frame: at baseline (Day 1) and Week 6

  2. arterial stiffness

    arterial stiffness measured by pulse wave velocity

    Time frame: at baseline (Day 1) and week 6

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The data and protocol can be shared with other researchers by request after publication.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

Time frame: The IPD information will be available 1-1-2027 for six months.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07453550
Lead sponsor
University of Hartford
Responsible party
Jinghui Yang (Assistant Professor, University of Hartford) — Principal investigator
First posted
Mar 6, 2026
Start date
Feb 1, 2026
Primary completion
Dec 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
May 1, 2026

Study contacts

Jinghui Yang, PT, MPT, PhD
Contact
jiyang@hartford.edu
347-429-0843

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion